CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation
Tae Hoon Kim, Chin Kook Rhee, Yeon-Mok Oh
Tuberc Respir Dis. 2019;82(1):35-41.   Published online December 19, 2018
DOI: https://doi.org/10.4046/trd.2018.0050

Excel Download

Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation
Tuberculosis and Respiratory Diseases. 2019;82(1):35   Crossref logo
Link1 Link2 Link3

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study
International Journal of Chronic Obstructive Pulmonary Disease. 2017;Volume 12:1589-1596   Crossref logo
Link1 Link2

<p>Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation</p>
Therapeutics and Clinical Risk Management. 2019;Volume 15:377-387   Crossref logo
Link1 Link2

Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung
Respiratory Medicine. 2003;97(11):1237-1242   Crossref logo
Link1 Link2

Effect of Airflow Limitation on Acute Exacerbations in Patients with Destroyed Lungs by Tuberculosis
Journal of Korean Medical Science. 2015;30(6):737   Crossref logo
Link1 Link2 Link3

Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung
BMC Pulmonary Medicine. 2021;21(1):   Crossref logo
Link1 Link2 Link3

Transforming Growth Factor-β1 and Tumor Necrosis Factor-α are Associated with Clinical Severity and Airflow Limitation of COPD in an Additive Manner
Lung. 2013;192(1):95-102   Crossref logo
Link1 Link2 Link3

Efficacy and Tolerability of Once-Daily Indacaterol 75 μg in COPD Patient Subgroups Defined by Age, Gender, Severity of Airflow Limitation, and Smoking Status
Chest. 2012;142(4):693A   Crossref logo
Link1 Link2

Management of asthma and chronic airflow limitation: Are methylxanthines obsolete?
Lung. 1990;168(S1):634-641   Crossref logo
Link1 Link2 Link3

Physiological Basis of Tests for Airflow Limitation
Tuberculosis and Respiratory Diseases. 1990;37(2):131-139   Crossref logo
Link1 Link2 Link3